Cresco Labs Inc. (CRLBF) income statement
CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 6, 2026Score 4/30
$0.58−0.02 (-3.13%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Cresco Labs Inc. income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- 49.5%
- Operating margin
- -4.3%
- Net margin
- -20.6%
- Return on equity, FY2025
- -33.2%
Financial strength
- Current ratio
- 2.59
- Debt to equity
- 1.27
- Debt to assets
- 36.0%
- Cash to current liabilities
- 57.8%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?